Form 4 Filing: ROTHBLATT MARTINE A Exercises Options for $5.7M of $UTHR

OPTION EXERCISE

⚡ MATERIALITY: 7/10

corporate issuer

UNITED THERAPEUTICS Corp

Ticker: $UTHR

Transaction Value

$5.7M

Price/Share: $299.31

transaction date

2026-09-28

Shares: 19,000

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, ROTHBLATT MARTINE A, holds the title of Chairperson & CEO at UNITED THERAPEUTICS Corp.

On 2026-09-28, the insider transacted 19,000 shares.The shares were transacted at a weighted average price of $299.31 per share, resulting in a total market-relevant value of $5.7M.

Executive Summary Summary

ROTHBLATT MARTINE A (Chairperson & CEO) exercised options for $5.7M of $UTHR

Post-Transaction Position: 333,943 shares

SEC Accession No: 0001106578-26-000151 (CIK: 1106578)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$UTHR Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$UTHR News Coverage